Safe passage: data control in the clinical trials cold chain
|A precise balance must be struck between risk and the cost of issues like controlled room temperature clinical trial shipments.|Developing stability data upfront before trials begin is necessary, as all products are affected by temperature and humidity.|Lisbeth Nielsen is the senior clinical supply technician at Danish pharma company Lundbeck, where she is responsible for setting up the outsourcing of distribution of IMPs. Educated as a pharmaconomist, she has worked in hospitals as well as the private sector.